You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ROIV Sale Disclosure
Venker Eric · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$7.32M
Venker Eric President & Immunovant CEO
ROIV
Roivant Sciences Ltd
ROIV
Transaction date
Sep 30, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 2 days later
ROIV daily price context
Close on/before transaction
$36.57
Sep 30, 2026
First close after public filing
$35.78
Oct 5, 2026
30-day return after filing
+0.31%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 200,000 shares @ $36.62
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001635088-26-000108
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$8.09M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Roivant Sciences Ltd. ROIV | Exercise | Sep 30, 2026 | $770K |
| Roivant Sciences Ltd. ROIV | Exercise | Sep 30, 2026 | $0 |
| Roivant Sciences Ltd. ROIV Current | Sale | Sep 30, 2026 | $7.32M |